Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm Metastasis × ponatinib × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 2 Neoplasms by Histologic Type 1 Neoplasms 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Diseases 1 Bone Marrow Diseases 1 Blast Crisis 1

Interventions

Specimen Handling 38 pembrolizumab 36 Biopsy 34 Magnetic Resonance Spectroscopy 30 Nivolumab 19 Paclitaxel 15 Radiosurgery 11 Gemcitabine 11 Carboplatin 11 trastuzumab deruxtecan 10 Fulvestrant 10 Capecitabine 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Ipilimumab 9 Fluorouracil 9 Cisplatin 9 Drug Therapy 8 Cyclophosphamide 8 Cetuximab 8 130-nm albumin-bound paclitaxel 8 atezolizumab 7 abemaciclib 7 Oxaliplatin 7 palbociclib 6 X-Rays 6 Trastuzumab 6 Standard of Care 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡